Kraj: Wielka Brytania
Język: angielski
Źródło: VMD (Veterinary Medicines Directorate)
Guaifenesin
Eurovet Animal Health B.V.
QM03BX90
Guaifenesin
Solution for infusion
POM-V - Prescription Only Medicine – Veterinarian
Horses
Neurological Agent muscle relaxant
Authorized
2012-08-31
Revised: August 2017 AN: 01224/2016 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Myorelax 100 mg/ml solution for infusion for horses 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml contains: Active substance:Guaifenesin 100 mg Excipients: For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Clear, colourless to light brown solution for infusion. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Horses. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Induction of muscle relaxation and immobilisation, as an adjunct to balanced anaesthesia. Depending on the procedure, guaifenesin can be used in combination with different anaesthetics: - in combination with a sedative, and local anaesthetics for short procedures - in combination with appropriate general anaesthetics, for induction and/or maintenance of muscle relaxation during anaesthesia. 4.3 CONTRAINDICATIONS None. Revised: August 2017 AN: 01224/2016 Page 2 of 6 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Guaifenesin should not be used alone. Animals must be properly sedated before immobilisation with the veterinary medicinal product. Adequate analgesia should always be provided for surgical and/or painful procedures. Animals should undergo a thorough pre-anaesthetic examination before administration of the product. Except in the case of an acute emergency, feed should be withheld for 12 hours prior to anaesthesia. Water should be freely available until a short time before anaesthesia. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Due to the irritative effects of the solution, it should be administered strictly intravenously using a catheter. See also section 4.6. Animals with anaemia, cardiac or respiratory problems or animals with other signs of disease should be monitored extra carefully. Special precautions to be taken by the person administering the veterinary medicinal product to animals People with known hypersensitivity to guaifenesin should avoid contact with the v Przeczytaj cały dokument